We reported that down-regulation of CHIT1, SIGLEC15, PLA2G2D and TMEM163 was associated with poor prognosis in immunocompetent NHL, and expression levels of four genes were lower in lymphoma than in normal tissues. The gene discussed is PLA2G2D; the disease is non-Hodgkin lymphoma.